3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase NA
1
Status
Completed
39
Terminated
8
Withdrawn
6
Unknown
6
Recruiting
3
Sponsor Class
OTHER
49
INDUSTRY
32
OTHER_GOV
4
NETWORK
3
NIH
2
Study Type
Interventional
3
Sponsor
Cancer Type
Gynecologic
3
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
15
Neoplasms
12
Multiple Myeloma
11
Carcinoma, Non-Small-Cell Lung
11
Melanoma
9
Pancreatic Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma
6
Colorectal Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lung Neoplasms
5
Leukemia, Myeloid, Acute
5
Hodgkin Disease
5
Sarcoma
4
Ovarian Neoplasms
4
Osteosarcoma
4
Hematologic Neoplasms
4
Brain Neoplasms
4
Teratoma
3
Smoldering Multiple Myeloma
3
Small Cell Lung Carcinoma
3
Recurrence
3
Neoplasms, Germ Cell and Embryonal
3
Neoplasm Metastasis
3
Malignant Solid Neoplasm
3
HIV Infections
3
Fallopian Tube Neoplasms
3
Colonic Neoplasms
3
Interventions
Letrozole
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
NETWORK
×
Fallopian Tube Neoplasms
×
Clear all
NCT06466382
2026-05-05
OVPrecision
Swiss GO Trial Group
Phase NA
Recruiting
60 enrolled
NCT05659381
2026-04-16
HOTT
GOG Foundation
Phase 3
Recruiting
220 enrolled
NCT04111978
2025-09-29
MATAO
Swiss GO Trial Group
Phase 3
Recruiting
540 enrolled